V. Kovač, MD, PhD, A. Franko, M. Dodič-Fikfak, N. Arnerić, and V. Dolžan, “Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma”, Radiol Oncol, vol. 49, no. 3, Oct. 2015.